Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongzhao Li

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Sensors (Basel, Switzerland)|January 8, 2020
Interference-Aware Radio Resource Management for Cognitive High-Throughput Satellite SystemsRui Zhang, Yuhan Ruan, Yongzhao Li, et al.
Sensors (Basel, Switzerland)|January 17, 2020
Defending Against Randomly Located Eavesdroppers by Establishing a Protecting RegionTao Li, Chaozheng Xue, Yongzhao Li, et al.
Open Medicine (Warsaw, Poland)|January 11, 2018
Docetaxel/cisplatin Therapy in Myasthenia Gravis with Hypertension/diabetesGuoyan Qi, Yinping Xue, Yongzhao Li, et al.
Journal of Ovarian Research|April 16, 2026
Diagnostic performance of deep learning models on ultrasound images for distinguishing benign from malignant ovarian cystsWeimei Li, Yuhua Xia, Yongzhao Li, et al.
Alternative Therapies in Health and Medicine|March 22, 2024
The Mechanism of miR-29 in Bladder Cancer Released by Exosomes into Brain Microglia to Promote M2 Polarization and Angiogenesis in Brain Metastasis of Bladder CancerHaopeng Tan, Yongzhao Li, Jianhua Li, et al.
IET Nanobiotechnology|October 2, 2019
ISI-mitigating modulation scheme using ion reaction for molecular communicationsDongliang Jing, Yongzhao Li, Rongnan Hang, et al.
Frontiers in Medicine|December 22, 2025
CT-integrated pathophysiology-guided, clinically causal cognition-led interpretable lesion context characterization and risk reasoning in lung MWAMeng Li, Yongzhao Li, Xiangming Wang, et al.
Investigational New Drugs|June 15, 2023
POTEE mutation as a potential predictive biomarker for immune checkpoint inhibitors in lung adenocarcinomaYongzhao Li, Qidong Yang, Yaqin Liu, et al.
Neurology and Therapy|November 19, 2025
Efgartigimod Combined with Glucocorticoids in the Treatment of Severe Generalized Myasthenia Gravis: A Single-Center, Retrospective Cohort StudyShanshan Gu, Yongzhao Li, Huimin Dong, et al.
Frontiers in Immunology|March 18, 2026
Targeting copper death-related long non-coding RNAs: a novel strategy to overcome immunotherapy resistance in liver cancerXiyang Sheng, Chen Mi, Gengyuan Shi, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Sensors (Basel, Switzerland)|January 8, 2020
Interference-Aware Radio Resource Management for Cognitive High-Throughput Satellite SystemsRui Zhang, Yuhan Ruan, Yongzhao Li, et al.
Sensors (Basel, Switzerland)|January 17, 2020
Defending Against Randomly Located Eavesdroppers by Establishing a Protecting RegionTao Li, Chaozheng Xue, Yongzhao Li, et al.
Open Medicine (Warsaw, Poland)|January 11, 2018
Docetaxel/cisplatin Therapy in Myasthenia Gravis with Hypertension/diabetesGuoyan Qi, Yinping Xue, Yongzhao Li, et al.
Journal of Ovarian Research|April 16, 2026
Diagnostic performance of deep learning models on ultrasound images for distinguishing benign from malignant ovarian cystsWeimei Li, Yuhua Xia, Yongzhao Li, et al.
Alternative Therapies in Health and Medicine|March 22, 2024
The Mechanism of miR-29 in Bladder Cancer Released by Exosomes into Brain Microglia to Promote M2 Polarization and Angiogenesis in Brain Metastasis of Bladder CancerHaopeng Tan, Yongzhao Li, Jianhua Li, et al.
IET Nanobiotechnology|October 2, 2019
ISI-mitigating modulation scheme using ion reaction for molecular communicationsDongliang Jing, Yongzhao Li, Rongnan Hang, et al.
Frontiers in Medicine|December 22, 2025
CT-integrated pathophysiology-guided, clinically causal cognition-led interpretable lesion context characterization and risk reasoning in lung MWAMeng Li, Yongzhao Li, Xiangming Wang, et al.
Investigational New Drugs|June 15, 2023
POTEE mutation as a potential predictive biomarker for immune checkpoint inhibitors in lung adenocarcinomaYongzhao Li, Qidong Yang, Yaqin Liu, et al.
Neurology and Therapy|November 19, 2025
Efgartigimod Combined with Glucocorticoids in the Treatment of Severe Generalized Myasthenia Gravis: A Single-Center, Retrospective Cohort StudyShanshan Gu, Yongzhao Li, Huimin Dong, et al.
Frontiers in Immunology|March 18, 2026
Targeting copper death-related long non-coding RNAs: a novel strategy to overcome immunotherapy resistance in liver cancerXiyang Sheng, Chen Mi, Gengyuan Shi, et al.
Pageof 2